iCare
Holly Swain is currently the VP of Medical & Professional Affairs at Icare USA, Inc. Previously, Holly worked as an Area Manager at Ruffatti Ophthalmic Instruments. Holly holds a Doctorate in Optometry from Illinois College of Optometry and a Bachelor of Applied Science in Biology/Biological Sciences from Ferris State University.
This person is not in any offices
iCare
iCare is a trusted partner in ophthalmic management offering medical devices to aid in screening and diagnosing ocular disease. Cutting-edge technology, ease of use and operational reliability are the cornerstones of iCare’s success. The iCare medical device product line consists of – retinal imaging – fundus perimeters – rebound tonometers - software solutions. iCare retinal imaging offers TrueColor Confocal technology providing enhanced image quality in a fully automated platform. This combined with the panoramic option makes diagnostic and retinal screening fast and easy. iCare fundus perimetry is the first automated perimeter that combines visual field testing with retinal tracking and fundus imaging. This enables real-time compensation for eye movements and increased test reliability. iCare rebound tonometry uses patented technology to obtain reliable and rapid IOP measurements without the need for anesthetic drops. This unique technology used by clinics is now available for patients to gather more IOP data at home. iCare software solutions are intuitive digital tools that facilitate efficiency and enhance continuity of care by connecting eye care pathways. iCare is a registered trademark of Icare Finland Oy, Icare USA, Inc., Icare World Australia Pty Ltd and CenterVue S.p.A. are parts of Revenio Group and represent the brand iCare. We believe ophthalmic care should be accessible, effortless and reliable. Our mission is to establish the next level of eye care.